Roivant Sciences Ltd.
NASDAQ:ROIV
11.07 (USD) • At close January 15, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 6,535.706 | 1,676.813 | 2,060.4 | 2,055.044 | 2,185.482 |
| Short Term Investments
| 5.367 | 5.011 | 0 | 77.701 | 0 |
| Cash and Short Term Investments
| 6,541.073 | 1,681.824 | 2,060.4 | 2,132.745 | 2,185.482 |
| Net Receivables
| 82.813 | 37.644 | 6.732 | 13.832 | 15.279 |
| Inventory
| 35.251 | 2.761 | 0 | 0 | 0 |
| Other Current Assets
| 72.691 | 81.267 | 79.391 | 40.418 | 18.484 |
| Total Current Assets
| 6,731.828 | 1,798.587 | 2,146.523 | 2,186.995 | 2,219.245 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 65.95 | 92.337 | 86.949 | 77.028 | 73.932 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 137.842 | 144.881 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 137.842 | 144.881 | 0 | 0 | 0 |
| Long Term Investments
| 247.753 | 304.317 | 325.834 | 289.541 | 177.215 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 39.109 | 49.482 | 25.823 | 36.128 | 6.659 |
| Total Non-Current Assets
| 490.654 | 591.017 | 438.606 | 402.697 | 257.806 |
| Total Assets
| 7,222.482 | 2,389.604 | 2,585.129 | 2,689.692 | 2,477.051 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 53.225 | 37.83 | 34.583 | 20.55 | 10.306 |
| Short Term Debt
| 21.893 | 52.413 | 11.398 | 12.313 | 7.839 |
| Tax Payables
| 10.469 | 0.542 | 0.708 | 0 | 0.413 |
| Deferred Revenue
| 4.168 | 12.444 | 10.147 | 5.918 | 3.621 |
| Other Current Liabilities
| 177.003 | 169.219 | 127.531 | 180.18 | 69.939 |
| Total Current Liabilities
| 266.758 | 272.448 | 184.367 | 218.961 | 92.118 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 477.856 | 428.991 | 272.493 | 232.664 | 173.044 |
| Deferred Revenue Non-Current
| 0 | 0 | 13.74 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 29.339 | 80.578 | 53.095 | 76.062 | 103.194 |
| Total Non-Current Liabilities
| 507.195 | 509.569 | 339.328 | 308.726 | 276.238 |
| Total Liabilities
| 773.953 | 782.017 | 523.695 | 527.687 | 368.356 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| 576.172 | -3,772.754 | -2,763.724 | -1,918.462 | -1,109.228 |
| Accumulated Other Comprehensive Income/Loss
| -4.083 | -2.617 | -0.946 | 1.445 | -2.349 |
| Other Total Stockholders Equity
| 5,396.492 | 4,933.137 | 4,421.614 | 3,714.805 | 3,143.739 |
| Total Shareholders Equity
| 5,968.581 | 1,157.766 | 1,656.944 | 1,797.788 | 2,032.162 |
| Total Equity
| 6,448.529 | 1,607.587 | 2,061.434 | 2,062.005 | 2,108.695 |
| Total Liabilities & Shareholders Equity
| 7,222.482 | 2,389.604 | 2,585.129 | 2,589.692 | 2,477.051 |